Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$ 2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal. Type 1 is the most severe, while Type 2 also causes major disability and loss of motor function.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$ 2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal. Type 1 is the most severe, while Type 2 also causes major disability and loss of motor function.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$ 2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal. Type 1 is the most severe, while Type 2 also causes major disability and loss of motor function.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$ 2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal. Type 1 is the most severe, while Type 2 also causes major disability and loss of motor function.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$ 2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal. Type 1 is the most severe, while Type 2 also causes major disability and loss of motor function.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$ 2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal. Type 1 is the most severe, while Type 2 also causes major disability and loss of motor function.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$ 2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal. Type 1 is the most severe, while Type 2 also causes major disability and loss of motor function.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$ 2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal. Type 1 is the most severe, while Type 2 also causes major disability and loss of motor function.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow us for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow us for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow us for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal.
Urgent
50 days left
Save Kaashvi & Arohvi. Every Day Counts.
Two sisters diagnosed with Spinal Muscular Atrophy need life-saving gene therapy Zolgensma which costs $1.1 M per child.
₹4.5 cr
Raised.
₹18 cr
Goal
$514 K
$2.2 M
Urgent
50 days left
Two SMA Warriors. One Chance, One Fight.
At just 2 months old, Arohvi has SMA Type 1 – the most aggressive form. The Zolgensma treatment must happen soon.
Follow us for more updates :
Urgent
58 days left
Understanding SMA: A Silent Killer
SMA gradually weakens muscles needed for movement, breathing, and swallowing. It robs children of the ability to sit, stand, or walk — and without timely treatment, can be fatal.
Choose your preferred platform to donate
We've made it easy to contribute through trusted fundraising platforms. Every dollar, every rupee goes directly toward Kaashvi and Arohvi's treatment.
Choose your preferred platform to donate
We've made it easy to contribute through trusted fundraising platforms. Every dollar, every rupee goes directly toward Kaashvi and Arohvi's treatment.
Choose your preferred platform to donate
We've made it easy to contribute through trusted fundraising platforms. Every dollar, every rupee goes directly toward Kaashvi and Arohvi's treatment.
Meet Kaashvi & Arohvi - Two SMA Warriors
Meet Kaashvi & Arohvi - Two SMA Warriors
Learn about each sister's unique journey and how Zolgensma gene therapy can transform their lives forever.
Learn about each sister's unique journey and how Zolgensma gene therapy can transform their lives forever.
Learn about each sister's unique journey and how Zolgensma gene therapy can transform their lives forever.
Verified Medical Documentation
Verified Medical Documentation
Complete transparency with official medical records from AIIMS Delhi and treating physician Prof. Sheffali Gulati, AIIMS Delhi. All documents available for verification.
Complete transparency with official medical records from AIIMS Delhi and treating physician Prof. Sheffali Gulati, AIIMS Delhi. All documents available for verification.
Kaashvi's Diagnosis
Date: June 23
Type: SMA Type 2
Status: Currently on Risdiplam therapy
Prof. Sheffali Gulati, AIIMS Delhi
Arohvi's Diagnosis
Date: July 25, 2025
Type: SMA Type 1
Status: Requires immediate Zolgensma
Prof. Sheffali Gulati, AIIMS Delhi
Kaashvi's Diagnosis
Date: June 23
Type: SMA Type 2
Status: Currently on Risdiplam therapy
Prof. Sheffali Gulati, AIIMS Delhi
Arohvi's Diagnosis
Date: July 25, 2025
Type: SMA Type 1
Status: Requires immediate Zolgensma
Prof. Sheffali Gulati, AIIMS Delhi
Kaashvi's Diagnosis
Date: June 23
Type: SMA Type 2
Status: Currently on Risdiplam therapy
Prof. Sheffali Gulati, AIIMS Delhi
Arohvi's Diagnosis
Date: July 25, 2025
Type: SMA Type 1
Status: Requires immediate Zolgensma
Prof. Sheffali Gulati, AIIMS Delhi
Media Coverage
Media Coverage
Transform lives through Corporate CSR Initiative
Transform lives through Corporate CSR Initiative
Partner with Care Guru Foundation to save Kaashvi and Arohvi. Your contribution qualifies for full CSR compliance and tax benefits.
Partner with Care Guru Foundation to save Kaashvi and Arohvi. Your contribution qualifies for full CSR compliance and tax benefits.
🏢 Official CSR Compliance
Partner: Care Guru Foundation (CGF)
Section 12AB & 80G certified
MCA registered for CSR activities
CSR Registration: CSR00086062
Darpan ID: DL/2024/0381238
📋 What Your Company Gets:
Full CSR documentation & certificates
Tax deduction benefits (Section 80G)
Regular treatment progress reports
Complete fund utilization transparency
Employee engagement success story
CSR compliance certificate for annual reporting
🏢 CSR Compliance
Partner: Care Guru Foundation (CGF)
Section 12AB & 80G certified
MCA registered for CSR activities
CSR Registration: CSR00086062
Darpan ID: DL/2024/0381238
📋 What Your Company Gets:
Full CSR documentation & certificates
Tax deduction benefits (Section 80G)
Regular treatment progress reports
Complete fund utilization transparency
Employee engagement success story
CSR compliance certificate for annual reporting
🏢 Official CSR Compliance
Partner: Care Guru Foundation (CGF)
Section 12AB & 80G certified
MCA registered for CSR activities
CSR Registration: CSR00086062
Darpan ID: DL/2024/0381238
📋 What Your Company Gets:
Full CSR documentation & certificates
Tax deduction benefits (Section 80G)
Regular treatment progress reports
Complete fund utilization transparency
Employee engagement success story
CSR compliance certificate for annual reporting
⚡ Lives at Critical Risk
Kaashvi (2.8 yrs): SMA Type 2 - losing mobility
Arohvi (2.5 months): SMA Type 1 - fatal without treatment
Solution: Zolgensma gene therapy (one-time, life-saving)
✅ Perfect CSR Alignment:
Healthcare & Medical Relief (primary CSR category)
Children Welfare (both are minors)
Rare Disease Support (underserved need)
Middle-class Family Crisis Support
⚡ Lives at Critical Risk
Kaashvi (2.8 yrs): SMA Type 2 - losing mobility
Arohvi (2.5 months): SMA Type 1 - fatal without treatment
Solution: Zolgensma gene therapy (one-time, life-saving)
✅ Perfect CSR Alignment:
Healthcare & Medical Relief (primary CSR category)
Children Welfare (both are minors)
Rare Disease Support (underserved need)
Middle-class Family Crisis Support
⚡ Lives at Critical Risk
Kaashvi (2.8 yrs): SMA Type 2 - losing mobility
Arohvi (2.5 months): SMA Type 1 - fatal without treatment
Solution: Zolgensma gene therapy (one-time, life-saving)
✅ Perfect CSR Alignment:
Healthcare & Medical Relief (primary CSR category)
Children Welfare (both are minors)
Rare Disease Support (underserved need)
Middle-class Family Crisis Support
🤝 Ready to Partner?
Contact Information:
CSR Queries: donorcare@careguruFoundation.org
Family Direct: keshav.kundu88@gmail.com | +91-7501496545
Simple 4-Step Process:
Initial Discussion → Understand your CSR priorities
Documentation → Medical reports, certificates, treatment plan
Contribution → Through Care Guru Foundation (full compliance)
Updates → Regular medical & utilization reports
🤝 Ready to Partner?
Contact Information:
CSR Queries: donorcare@careguruFoundation.org
Family Direct: keshav.kundu88@gmail.com | +91-7501496545
Simple 4-Step Process:
Initial Discussion → Understand your CSR priorities
Documentation → Medical reports, certificates, treatment plan
Contribution → Through Care Guru Foundation (full compliance)
Updates → Regular medical & utilization reports
🤝 Ready to Partner?
Contact Information:
CSR Queries: donorcare@careguruFoundation.org
Family Direct: keshav.kundu88@gmail.com | +91-7501496545
Simple 4-Step Process:
Initial Discussion → Understand your CSR priorities
Documentation → Medical reports, certificates, treatment plan
Contribution → Through Care Guru Foundation (full compliance)
Updates → Regular medical & utilization reports
Time is running out. Every Hour Matters
Time is running out. Every Hour Matters
Arohvi has SMA Type 1. Without immediate Zolgensma treatment, most babies don't survive beyond age 2. She needs your help TODAY.
Arohvi has SMA Type 1. Without immediate Zolgensma treatment, most babies don't survive beyond age 2. She needs your help TODAY.
How Can You Save Two Lives Today?
How Can You Save Two Lives Today?
Every action counts in the race to save Kaashvi and Arohvi. Choose how you want to be part of their life-saving journey.
Every action counts in the race to save Kaashvi and Arohvi. Choose how you want to be part of their life-saving journey.
Make a Donation
Every dollar brings us closer to the $2.1 million needed. Whether it's $100 or $10,000, your contribution directly funds their Zolgensma treatment.
Make a Donation
Every dollar brings us closer to the $2.1 million needed. Whether it's $100 or $10,000, your contribution directly funds their Zolgensma treatment.
Make a Donation
Every dollar brings us closer to the $2.1 million needed. Whether it's $100 or $10,000, your contribution directly funds their Zolgensma treatment.
Spread Their Story
Share Kaashvi and Arohvi's story with your network. Help us reach more hearts and multiply our impact through the power of community.
Spread Their Story
Share Kaashvi and Arohvi's story with your network. Help us reach more hearts and multiply our impact through the power of community.
Spread Their Story
Share Kaashvi and Arohvi's story with your network. Help us reach more hearts and multiply our impact through the power of community.
Reach Company HR
Reach out to your company HR to save lives. Corporate contributions and employee matching programs can make an enormous difference in reaching our goal.
Reach Company HR
Reach out to your company HR to save lives. Corporate contributions and employee matching programs can make an enormous difference in reaching our goal.
Reach Company HR
Reach out to your company HR to save lives. Corporate contributions and employee matching programs can make an enormous difference in reaching our goal.